Table 6.
Bravecto™ (fluralaner) | Frontline™ (fipronil) | p value | Lower 97.5% 1-sided C.I. a | |
---|---|---|---|---|
Fleas |
|
|
|
|
Week 2 |
89.57% |
62.30% |
<0.0001 |
0.1498 |
Week 4 |
94.87% |
63.93% |
<0.0001 |
0.1916 |
Week 8 |
95.65% |
70.49% |
<0.0001 |
0.1416 |
Week 12 |
97.39% |
81.97% |
<0.0001 |
0.0586 |
Ticks |
|
|
|
|
Week 2 |
97.67% |
89.47% |
0.0006 |
-0.0575 |
Week 4 |
97.67% |
84.21% |
0.0001 |
-0.0175 |
Week 8 |
97.67% |
94.74% |
0.0024 |
-0.0953 |
Week 12 | 100.0% | 100.0% | n/ab | n/ab |
aResult greater than -0.15 required to declare significant non-inferiority. Result greater than 0 required to declare significant one-sided superiority with α = 0.025.
bNo statistical test as all households were free of ticks at week 12.
n/a: not applicable.